Security key
31189P102
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)
CUSIP: 31189P102
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 122,342,805
- Total 13F shares
- 122,980,750
- Share change
- +27,801,314
- Total reported value
- $902,678,660
- Put/Call ratio
- 22%
- Price per share
- $7.34
- Number of holders
- 160
- Value change
- +$225,457,297
- Number of buys
- 85
- Number of sells
- 78
Report period
Q1 2024
Institutions
160
Top holders
10
FATE full security history
Newer quarter: Q2 2024
Previous quarter: Q4 2023
FATE THERAPEUTICS INC SEC filings
FATE THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 31189P102
Recent filing periods:
Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
|
Company |
11%
|
13,169,057
|
$49,252,273 | — | 31 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
9.2%
|
11,212,816
|
$41,935,933 | — | 31 Dec 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.6%
|
9,293,363
|
$34,757,178 | — | 31 Dec 2023 | |
| Bellevue Group AG |
13F
|
Company |
4%
|
4,851,579
|
$18,144,905 | — | 31 Dec 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.9%
|
3,581,979
|
$13,396,601 | — | 31 Dec 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2.9%
|
3,489,163
|
$13,049,470 | — | 31 Dec 2023 | |
| JOHNSON & JOHNSON |
13F
|
Company |
2.8%
|
3,379,064
|
$12,637,699 | — | 31 Dec 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.2%
|
2,666,208
|
$9,971,618 | — | 31 Dec 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
2.1%
|
2,616,820
|
$9,786,907 | — | 31 Dec 2023 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.9%
|
2,281,171
|
$8,530,000 | — | 31 Dec 2023 | |
| Monaco Asset Management SAM |
13F
|
Company |
1.8%
|
2,183,228
|
$8,165,273 | — | 31 Dec 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.7%
|
2,072,506
|
$7,751,172 | — | 31 Dec 2023 | |
| Casdin Capital, LLC |
13F
|
Company |
1.7%
|
2,050,000
|
$7,667,000 | — | 31 Dec 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.5%
|
1,876,900
|
$7,019,606 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,863,485
|
$6,970,176 | — | 31 Dec 2023 | |
| STATE STREET CORP |
13F
|
Company |
1.5%
|
1,861,919
|
$6,963,577 | — | 31 Dec 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.5%
|
1,849,872
|
$6,918,521 | — | 31 Dec 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.4%
|
1,700,000
|
$6,358,000 | — | 31 Dec 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.3%
|
1,550,659
|
$5,799,465 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
1,321,356
|
$4,941,872 | — | 31 Dec 2023 | |
| Vestal Point Capital, LP |
13F
|
Company |
1.1%
|
1,290,000
|
$4,824,600 | — | 31 Dec 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.8%
|
983,019
|
$3,676,491 | — | 31 Dec 2023 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.74%
|
900,000
|
$3,366,000 | — | 31 Dec 2023 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.73%
|
898,196
|
$3,359,253 | — | 31 Dec 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.73%
|
893,648
|
$3,342,244 | — | 31 Dec 2023 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.69%
|
847,823
|
$3,170,858 | — | 31 Dec 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.69%
|
843,962
|
$3,156,418 | — | 31 Dec 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.58%
|
711,287
|
$2,660,214 | — | 31 Dec 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.58%
|
708,589
|
$2,650,123 | — | 31 Dec 2023 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.57%
|
700,000
|
$2,618,000 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.5%
|
607,004
|
$2,270,195 | — | 31 Dec 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.48%
|
590,993
|
$2,210,314 | — | 31 Dec 2023 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.46%
|
560,011
|
$2,094,441 | — | 31 Dec 2023 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.43%
|
528,080
|
$1,975,019 | — | 31 Dec 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
0.41%
|
500,000
|
$1,870,000 | — | 31 Dec 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.41%
|
497,457
|
$1,860,489 | — | 31 Dec 2023 | |
| GCM Grosvenor Holdings, LLC |
13F
|
Company |
0.41%
|
495,916
|
$1,854,726 | — | 31 Dec 2023 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.32%
|
395,753
|
$1,480,000 | — | 31 Dec 2023 | |
| Woodline Partners LP |
13F
|
Company |
0.31%
|
385,364
|
$1,441,261 | — | 31 Dec 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.29%
|
359,375
|
$1,344,061 | — | 31 Dec 2023 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.29%
|
356,740
|
$1,334,208 | — | 31 Dec 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.26%
|
321,952
|
$1,204,101 | — | 31 Dec 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.26%
|
320,774
|
$1,200,100 | — | 31 Dec 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.26%
|
314,571
|
$1,176,496 | — | 31 Dec 2023 | |
| FMR LLC |
13F
|
Company |
0.24%
|
291,172
|
$1,088,983 | — | 31 Dec 2023 | |
| Man Group plc |
13F
|
Company |
0.21%
|
252,676
|
$945,008 | — | 31 Dec 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.21%
|
251,649
|
$941,168 | — | 31 Dec 2023 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.2%
|
244,684
|
$915,118 | — | 31 Dec 2023 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.19%
|
235,058
|
$879,117 | — | 31 Dec 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.19%
|
233,748
|
$874,217 | — | 31 Dec 2023 |
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q1 2024
As of 31 Mar 2024,
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by
160 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
122,980,750 shares.
The largest 10 holders included
Redmile Group, LLC, VANGUARD GROUP INC, BlackRock Inc., Boxer Capital, LLC, STATE STREET CORP, Deep Track Capital, LP, Bellevue Group AG, JOHNSON & JOHNSON, CITADEL ADVISORS LLC, and MORGAN STANLEY.
This page lists
162
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
152
Q1 2024 holders
160
Holder diff
8
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.